Sanseau, A.; Burchakchi, A.; Cataldi, F.; Fontana, H.; Peyret, A.; RodrÃguez, G.; Fantacone, A.; Passerini, M.S.; Casiraghi, J.F.
Real-World Transition to a Preservative-Free Fixed Combination of Dorzolamide/Timolol: Impact on the Ocular Surface Microenvironment, Safety, Tolerability, and Efficacy. Medicina 2026, 62, 184.
https://doi.org/10.3390/medicina62010184
AMA Style
Sanseau A, Burchakchi A, Cataldi F, Fontana H, Peyret A, RodrÃguez G, Fantacone A, Passerini MS, Casiraghi JF.
Real-World Transition to a Preservative-Free Fixed Combination of Dorzolamide/Timolol: Impact on the Ocular Surface Microenvironment, Safety, Tolerability, and Efficacy. Medicina. 2026; 62(1):184.
https://doi.org/10.3390/medicina62010184
Chicago/Turabian Style
Sanseau, Ana, Arturo Burchakchi, Fernando Cataldi, Héctor Fontana, Alejo Peyret, Giselle RodrÃguez, AilÃn Fantacone, MarÃa Silvia Passerini, and Javier F. Casiraghi.
2026. "Real-World Transition to a Preservative-Free Fixed Combination of Dorzolamide/Timolol: Impact on the Ocular Surface Microenvironment, Safety, Tolerability, and Efficacy" Medicina 62, no. 1: 184.
https://doi.org/10.3390/medicina62010184
APA Style
Sanseau, A., Burchakchi, A., Cataldi, F., Fontana, H., Peyret, A., RodrÃguez, G., Fantacone, A., Passerini, M. S., & Casiraghi, J. F.
(2026). Real-World Transition to a Preservative-Free Fixed Combination of Dorzolamide/Timolol: Impact on the Ocular Surface Microenvironment, Safety, Tolerability, and Efficacy. Medicina, 62(1), 184.
https://doi.org/10.3390/medicina62010184
